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Received November 29, 2012; accepted July 30, 2013AbstractBackground: Orthostatic intolerance (OI) is common but heterogeneous. There is a subgroup of OI patients who have excessive decrease in
cerebral blood flow velocity (CBFV) of bilateral middle cerebral arteries (MCAs) during head-up tilt without systemic blood pressure change.
This study evaluated the role of blood volume reduction in such patients.
Methods: Patients with idiopathic OI who had excessive orthostatic decrease (>20% of the supine level) in mean CBFVof bilateral MCAs and
who also received blood volume determination were collected. The chromium (51Cr) dilution method was used for red blood cell (RBC) volume
determination in these patients. The blood volume was expressed as a percentage of the expected volume. These patients were further divided
into two groups, those with postural tachycardia syndrome (POTS group) and those without (non-POTS group). The data of RBC volume were
compared between the two groups. Besides, we used multivariate linear regression to evaluate the factors that predict RBC volume.
Results: Twenty-five patients (13 females, median age ¼ 28 years) were enrolled in this study. Nine of these patients had POTS (5 females,
median age ¼ 26 years) and 16 did not (8 females, median age ¼ 29.5 years). Compared with the expected volume, the RBC volume was
significantly reduced in all patients (median ¼ 82% of the expected volume). Moreover, the RBC volume was significantly lower in the POTS
group than that in the non-POTS group (78% vs. 85% of the expected volume, p ¼ 0.013). The orthostatic decrease of MCA flow velocity was
28.3% in the POTS group and 32.5% in the non-POTS group (p ¼ 0.140). The orthostatic pulsatility index increment was 15.4% in the POTS
group and 20.5% in the non-POTS group (p ¼ 0.438). Moreover, basic demography and hemoglobin levels were not different between the two
groups. After multivariate linear regression (dependent variables including age, sex, body surface, and groups), only the presence of POTS
significantly predicted the RBC volume (p ¼ 0.006).
Conclusion: The results of our study indicated that low RBC volume may play an important role in the pathophysiology of OI in this group of
patients. Moreover, its role seems even more relevant in patients with POTS than in those without. Further studies for mechanistic evaluation are
needed in the future.
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Orthostatic intolerance (OI) is a group of heterogeneous
disorders. Associated symptoms include dizziness, exercise
intolerance, impaired concentration, and recurrent syncope,
most of which are reversible on lying supine. The aforemen-
tioned symptoms may also be present in patients with postural
hypotension, postural tachycardia syndrome (POTS), cerebralhinese Medical Association. All rights reserved.
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drome.1,2 Also, similar symptoms are often demonstrable in
chronic fatigue syndrome.3 Individuals affected by idiopathic
OI are usually young (15e45 years old), with female pre-
dominance (male/female ¼ 1:5), and the symptoms are sug-
gested to be related to diffuse cerebral hypoperfusion during
upright posture.1
On transcranial Doppler (TCD) studies, a subgroup of OI
patients were found to have significant decrement in mean
middle cerebral artery flow velocity (MCAFV) during head-up
tilt (HUT) without concomitant drop in systemic arterial blood
pressure.4 The orthostatic decrease of MCAFV was reported to
be as high as 30% from baseline in a case series.5 However, an
international consensus for diagnosing this group of patients is
still not available. Draffertshofer et al defined primary cere-
brovascular dysautoregulation syndrome as an excessive
decrease in TCD-derived MCAFV of more than 20%
compared with the supine level during orthostasis without
orthostatic hypotension, which is also adopted by our labora-
tory as the cut-off value.6 The mechanisms of excessive
orthostatic decrease in MCAFV still remain controversial. In
this study, we attempted to decipher the role of blood volume
in this group of OI patients with or without POTS. We hy-
pothesized that orthostatic tachycardia may be associated with
a more extensive decrement of red blood cell (RBC) volume in
POTS patients than in those without POTS among patients
with excessive orthostatic CBFV decrease.
2. Methods2.1. Study populationWe retrospectively reviewed all patients with chronic
orthostatic intolerance (>6 months) in our cerebral hemody-
namic laboratory who also received blood volume determi-
nation from August 2001 to October 2011. Only those with
excessive decrement in the mean MCAFV (more than 20% in
the first 5 minutes) during a 70 HUT and of age less than 50
years were included in this study. The exclusion criteria
included orthostatic hypotension [systolic or diastolic blood
pressure (BP) drop 20 mmHg and 10 mmHg during the first
5 minutes of HUT, respectively], carotid stenosis greater than
30%, anemia (<130 g/L for males and <120 g/L for females),
use of a and/or b adrenergic blockers, neurally mediated
syncope (vasovagal syncope), chronic heart failure, cardiac
arrhythmia, valvular or ischemic heart disease, epilepsy, his-
tory of vertebrobasilar insufficiency, stroke, electrolyte
imbalance, hyperventilation syndrome or panic disorders, and
other diseases that may adversely affect the autonomic ner-
vous systems, including chronic kidney disease (expected
glomerular filtration rate < 60 mL/minute), diabetes mellitus,
peripheral neuropathy, familial pandysautonomia, multiple
system atrophy, and amyloidosis. A total of 47 patients were
reviewed, and 25 patients met all the inclusion and exclusion
criteria. All of these participants had received complete
physical and neurological examinations, dizziness and auto-
nomic questionnaire, complete blood count, and serumbiochemistry tests based on the protocol of our laboratory. All
of these patients also underwent brain magnetic resonance
angiogram and electroencephalogram.
This case review study was approved by the internal review
board of Taipei Veterans General Hospital (201208011BC).2.2. TCD monitoring during HUTHUT examination required that each participant lie on a
motorized tilt table with foot board support. Real time beat-to-
beat arterial blood pressure and heart rate were recorded
noninvasively by an infrared finger plethysmography (Por-
tapres-Model 2; FMS, Amsterdam, The Netherlands) fixed to
the middle finger of the left hand.
A transcranial Doppler ultrasonographic monitor (Multi-
Dop X/TCD7; DWL, Sipplingen, Germany) was used to detect
MCAFV bilaterally. The transducer was fixed in place and the
flow continuously monitored at the point of optimum signal.
Each participant remained in the supine position for 10 mi-
nutes prior to tilting head-up to 70 for 30 minutes or until
syncopal symptoms developed. The mean MCAFV decrease
within the first 5 minutes after tilting from supine to upright
was presented as percentage. The pulsatility index (PI) was
measured and calculated by the equation:
PI ¼ (systolic velocity e diastolic velocity)/mean velocity.
PI level was measured in supine and upright positions,
respectively. The orthostatic PI change was presented as a ratio
of upright/supine.2.3. RBC volume determinationRBCs are labeled with 51Cr (Sodium Chromate-51Cr In-
jection, Fujifilm, Tokyo, Japan). The procedure was as fol-
lows: (1) approximately 25 mL of blood was obtained via vein
puncture and labeled with 100 mCi (3.7 MBq) of Na2
51CrO4 for
30 minutes; (2) 20 mL of the tagged blood was reinjected into
each patient’s circulation; (3) 20 mL of blood sample was
drawn for determination of radioactivity, from the opposite
arm at 30 minutes post-injection; (4) radioactive assays were
carried out on samples in the liquid state, with a conventional
well-type scintillation counter.
The blood volume determination was based on a dilution
technique: volume ¼ (quantity injected)/(concentration of
diluted tracer). The method for determining the RBC volume
has been described in previous communications and was
widely adopted with minor modifications.7,8 The expected
RBC volume was calculated according to previous literature as
1.1  body surface area in males and 0.84  body surface area
in females.9 The individual data for every participant were
expressed as a percentage of each expected volume, respec-
tively. The group data were expressed as the median (inter-
quartile range).2.4. Statistical analysisThe Wilcoxon rank sum test was used for group compari-
sons of all parameters except Fisher’s exact test for sex ratio.
Fig. 1. RBC volume is decreased in all patients. The RBC deficiency is
significantly more severe in POTS than in non-POTS. * p ¼ 0.013.
POTS ¼ postural orthostatic tachycardia syndrome; RBC ¼ red blood cell.
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group were set as independent variables. The RBC volume
was set as the dependent variable. Data were analyzed using
the SPSS software package (version 17; SPSS, Inc., Chicago,
IL, USA). Statistical significance was set at p < 0.05.
3. Results
The demographic data, hemoglobin, hematocrit, orthostatic
PI change, and MCAFV decrease during HUT are demon-
strated in Table 1. Tilt table TCD monitoring showed mild PI
increase and significant mean MCAFV decrease in bilateral
MCA during HUT in all patients. The RBC volume was
significantly reduced compared with the expected value (82%
of the expected volume). We further analyzed the data be-
tween non-POTS and POTS groups. The decreased RBC
volume was significantly more severe in the POTS group (78%
of the expected volume) than that in the non-POTS group
(85% of the expected volume; p ¼ 0.013; Fig. 1). The age of
the non-POTS group was slightly but not significantly older
than that of the POTS group. Meanwhile, the hemoglobin,
hematocrit, orthostatic PI change, and MCAFV drop between
the two groups were not significantly different. In multivariate
linear regression, patients with POTS significantly predicted
a smaller RBC volumes (p ¼ 0.006). Age, sex, and body
surface area were not significant predictors of RBC volume
(Table 2).
4. Discussion
In this study, we observed a significant reduction of RBC
volume in a group of OI patients with excessive orthostatic
decrement in MCAFV without concomitant systemic BP
change. We further demonstrated among these patients that
after controlling for age, sex, and body surface area, those with
POTS suffered from a more severe decrease in RBC volume
than did those without.Table 1
Basic characteristics and orthostatic TCD data.
All (n ¼ 25) Non-POTS
(n ¼ 16)
POTS (n ¼ 9) p
Age (y) 28 (20e34) 29.5 (21.5e43.5) 26 (17.5e34.5) 0.240
Surface
area (m2)
1.61 (1.53e1.74) 1.61 (1.54e1.74) 1.59 (1.53e1.65) 0.350
Sex
(M/F)
12:13 8:8 4:5 0.677
Hgb
(g/L)
141 (131e149) 141 (134e148) 138 (128e156) 0.377
Hct 40.9 (38.9e43.8) 41.3 (39.4e43.4) 40.2 (37.7e44.7) 0.497
PI
increment
18.1 (2.3e29.2) 20.5 (6.1e30.3) 15.4 (9.4e28.5) 0.438
MCAFV
drop
32.0 (27.5e35.5) 32.5 (30.6e35.8) 28.3 (26.2e33.2) 0.140
Data are presented as % unless otherwise indicated.
Hct ¼ hematocrit; Hgb ¼ hemoglobin; MCAFV ¼ middle cerebral artery flow
velocity; PI ¼ pulsatility index; POTS ¼ postural orthostatic tachycardia
syndrome.OI patients can be very disabled by many nonspecific
symptoms, including fatigue, palpitation, and shortness of
breath upon standing upright.10,11 POTS may be one of the
most common conditions of it. There is heterogeneity in
POTS, which includes partial dysautonomia and hyper-
adrenergic state as two of the major forms.12 In the former
form, symptoms derive from compensatory increase of heart
rate and myocardial contractility during upright induced blood
pooling. In the latter form, elevated norepinephrine level on
standing results in orthostatic tachycardia. In these patients,
excessive decrease in MCAFV during HUT was frequently
found.2,13 However, the mechanisms of abnormal orthostatic
MCAFV change have not yet been fully clarified. The
postulated hypotheses include cerebral vasoconstriction14 with
sympathetic supersensitivity, hypocapnea-associated vaso-
constriction,15,16 impaired cerebral autoregulation,4,17 exces-
sive venous pooling, decreased stroke volume related to
tachycardia, and decreased blood volume. Cerebral vasocon-
striction with an increase in PI during HUT is also shown in
our study.
Orthostasis results in gravitational blood pooling with
approximately 600 mL in the lower limbs and sympathetic
activation in both OI patients and normal individuals.18
However, compensation for these dynamic changes occurs
much more rapidly in healthy individuals. The plasma vol-
ume shift from vascular space to interstitial space is also
greatly enhanced in orthostasis of patients with OI.19 Several
studies showed that relative excessive cardiac sympatheticTable 2
Multivariate linear regression of RBC volumes.
b t Standard
error
p
Constant 1.311 0.484 0.205
Age 0.368 1.718 0.002 0.101
Sex 0.075 0.247 0.053 0.807
Surface area 0.227 0.707 0.268 0.487
Group (POTS) 0.580 3.065 0.034 0.006*
*p < 0.05, R2 ¼ 0.362.
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tightness, and tachycardia.20,21 With a similar mechanism,
sympathetic activity-related vasoconstriction may contribute
to the excessive cerebral blood flow decrease in the upright
posture.16,22
In addition to the fluid shift during orthostasis, baseline
hypovolemia, especially reduced effective RBC volume, was
also reported in orthostatic intolerance. Fouad et al23 reported
that significantly decreased blood volume is common in pa-
tients with OI. Streeten et al3 found that RBC volume was
significantly decreased in patients with chronic fatigue syn-
drome. Raj and Robertson24 indicated that significantly
decreased RBC and plasma volume were also demonstrated in
POTS patients compared with the control group. Low levels of
plasma renin activity and erythropeitin (EPO) have been hy-
pothesized to play a role in such deficiency.25 The relatively
reduced RBC mass and possible subsequent reduced oxygen-
ation in our patients may further exacerbate orthostatic
symptoms during HUT-related sympathetic activation.
Disordered autonomic regulation with normal serum renin
and low serum aldosterone levels have been reported in patients
with POTS.26 Differences in severity of decrement in effective
RBC volume may also account for differences in orthostatic
heart rate between OI patients with POTS and without POTS.
This is because a greater reduction in effectiveRBCvolumemay
contribute to a greater increase in orthostatic heart rate.26
Therefore, in addition to disordered autonomic regulation,
those patients with POTSwho have lower effective RBC volume
and are less effective in blood volume compensation than those
without POTS may respond to orthostatic stress with a greater
increase in orthostatic heart rate. There is evidence that pertur-
bation of the renineangiotensinealdosterone axis might result
from impaired sympathetic innervation of kidneys in POTS,
which resulted in hypovolemia being more severe in these pa-
tients.27 Therefore, regardless of documented autonomic
dysfunction in orthostatic tachycardia, effective RBC volume
deficiency may still play an important role in the underlying
pathophysiology.During the past decades, fluidmanagement has
been used to treat orthostatic symptoms in POTS patients, with
divergent results.28e30 Erythropeitin was also applied to treat
POTS patients, producing some benefits.31,32 However, data
regarding the patients’ RBC mass were not considered in these
studies. A trial to treat specificOI patients based onRBCvolume
may provide more precise guidance for clinical management.
To the best of our knowledge, this is the first study focusing
on RBC volume to discriminate the specific subgroups of
patients with idiopathic OI. Additionally, the Asian data on
POTS have been very limited to date. However, this study has
some limitations. First, the sample size is rather small because
not all of the idiopathic OI patients received the blood volume
determination in our laboratory. In addition, this study did not
include the autonomic function of these patients, which is
often abnormal in patients with idiopathic OI. Because there
was a discrepancy in orthostatic heart rate change between the
two groups, a more thorough autonomic evaluation may
clarify this issue. Lastly, due to ethical concerns, we did not
recruit a normal control group for the blood volumedetermination study. Future prospective research enrolling
more patients with improved matching with regard to gender is
needed to clarify the role of blood volume in these two groups
of patients. In conclusion, excessive decrement in MCAFV
during HUT without systemic arterial BP change is an
important feature among a subgroup of idiopathic OI patients.
In these patients, decreased RBC volume is frequently found.
The results of our study suggest that low RBC volume may
play an important role in its pathophysiology. Also, those with
POTS may suffer more severe deficiency of RBC volume than
those without. The pathophysiological mechanisms of RBC
volume deficiency deserve further elucidation.
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